BBIO   $25.16  -3.31% Market Closed After Close 25.07 -0.36%

BridgeBio Pharma Inc
Total Cash 447.77M
totalCashPerShare 2.381
EBITDA -496.59M
Total Debt 1.73B
quickRatio 3.337
currentRatio 4.586
Total Revenue 219.12M
debtToEquity
Revenue/Share 1.245
ROA -0.48437
ROE
grossProfits
freeCashflow -348.46M
operatingCashflow -414.88M
earningsGrowth
revenueGrowth 0.321
grossMargins 0.98907995
ebitdaMargins -2.2662601
operatingMargins -79.63469
profitMargins -2.07106
enterpriseValue 6.18B
forwardPE -8.276316
floatShares 127.53M
sharesOutstanding 188.03M
sharesShort 18.63M
sharesShortPriorMonth 17.71M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.93%
Short Ratio help_outline 6.34%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue -5.812
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -453.82M
trailingEps -2.64%
forwardEps -3.04%
enterpriseToEbitda -12.46
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.98 3Q 2024
institutionsCount 347
lastUpdated Oct. 21, 2024, 11:55 p.m.